Bone-targeted therapy: phase II study of strontium-89 in combination with alternating weekly chemohormonal therapies for patients with advanced androgen-independent prostate cancer (Q46211584)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Bone-targeted therapy: phase II study of strontium-89 in combination with alternating weekly chemohormonal therapies for patients with advanced androgen-independent prostate cancer |
scientific article |
Statements
1 reference
Bone-targeted therapy: phase II study of strontium-89 in combination with alternating weekly chemohormonal therapies for patients with advanced androgen-independent prostate cancer (English)
1 reference
Robert J Amato
1 reference
Joan Hernandez-McClain
1 reference
Haby Henary
1 reference
1 December 2008
1 reference
31
1 reference
532-538
1 reference
6
1 reference
Identifiers
1 reference
1 reference